Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock par value $0.012 per share
-
Shares outstanding
-
41M
-
Number of holders
-
114
-
Total 13F shares, excl. options
-
8.58M
-
Shares change
-
+3.04M
-
Total reported value, excl. options
-
$122M
-
Value change
-
+$40.9M
-
Put/Call ratio
-
0.49
-
Number of buys
-
74
-
Number of sells
-
-26
-
Price
-
$14.28
Significant Holders of ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) as of Q4 2021
137 filings reported holding ORMP - ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share as of Q4 2021.
ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) has 114 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.58M shares
of 41M outstanding shares and own 20.91% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.56M shares), MILLENNIUM MANAGEMENT LLC (762K shares), CITADEL ADVISORS LLC (534K shares), STATE STREET CORP (512K shares), TWO SIGMA INVESTMENTS, LP (402K shares), MORGAN STANLEY (387K shares), VANGUARD GROUP INC (285K shares), GEODE CAPITAL MANAGEMENT, LLC (245K shares), NORTHERN TRUST CORP (243K shares), and TWO SIGMA ADVISERS, LP (227K shares).
This table shows the top 114 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.